United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry

Date: November 30, 2012
Pages: 557
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: U587B5D66DBEN
Leaflet:

Download PDF Leaflet

United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData’s new report, “United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the United States In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
  • Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the United States In Vitro Diagnosticsmarket.
  • Key players covered include Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., Alere Inc. and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the United States In Vitro Diagnostics competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 IN VITRO DIAGNOSTICS IN UNITED STATES

3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2011
3.4 In Vitro Diagnostics Market, United States, Category Contribution (%), 2011
3.5 In Vitro Diagnostics, United States, Company Share (2010-2011)

4 CLINICAL CHEMISTRY IN UNITED STATES

4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, United States, Revenue Mix ($m), 2011
4.3 Clinical Chemistry Market, United States, Segment Contribution (%), 2011
4.4 Clinical Chemistry Overall Revenue, (2004-2018)
4.5 Clinical Chemistry Distribution Share (2010-2011)
4.6 Clinical Chemistry, United States, Company Share (2010-2011)

5 GENETIC TESTING IN UNITED STATES

5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, United States, Revenue Mix ($m), 2011
5.3 Genetic Testing Market, United States, Segment Contribution (%), 2011
5.4 Genetic Testing Overall Revenue, (2004-2018)
5.5 Genetic Testing Distribution Share (2010-2011)
5.6 Genetic Testing, United States, Company Share (2010-2011)

6 HAEMATOLOGY IN UNITED STATES

6.1 Haematology Market, Market Segmentation
6.2 Haematology Market, United States, Revenue Mix ($m), 2011
6.3 Haematology Market, United States, Segment Contribution (%), 2011
6.4 Haematology Overall Revenue, (2004-2018)
6.5 Haematology Distribution Share (2010-2011)
6.6 Haematology, United States, Company Share (2010-2011)

7 HISTOLOGY AND CYTOLOGY IN UNITED STATES

7.1 Histology and Cytology Market, Market Segmentation
7.2 Histology And Cytology Market, United States, Revenue Mix ($m), 2011
7.3 Histology And Cytology Market, United States, Segment Contribution (%), 2011
7.4 Histology And Cytology Overall Revenue, (2004-2018)
7.5 Histology And Cytology Distribution Share (2010-2011)
7.6 Histology And Cytology, United States, Company Share (2010-2011)

8 IMMUNO CHEMISTRY IN UNITED STATES

8.1 Infectious Immunology, Market Segmentation
8.2 Immuno Chemistry Market, United States, Revenue Mix ($m), 2011
8.3 Immuno Chemistry Market, United States, Segment Contribution (%), 2011
8.4 Immuno Chemistry Overall Revenue, (2004-2018)
8.5 Immuno Chemistry Distribution Share (2010-2011)
8.6 Immuno Chemistry, United States, Company Share (2010-2011)

9 INFECTIOUS IMMUNOLOGY IN UNITED STATES

9.1 Infectious Immunology Market, United States, Revenue Mix ($m), 2011
9.2 Infectious Immunology Market, United States, Segment Contribution (%), 2011
9.3 Infectious Immunology Overall Revenue, (2004-2018)
9.4 Infectious Immunology Distribution Share (2010-2011)
9.5 Infectious Immunology, United States, Company Share (2010-2011)

10 MICROBIOLOGY CULTURE IN UNITED STATES

10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, United States, Revenue Mix ($m), 2011
10.3 Microbiology Culture Market, United States, Segment Contribution (%), 2011
10.4 Microbiology Culture Overall Revenue, (2004-2018)
10.5 Microbiology Culture Distribution Share (2010-2011)
10.6 Microbiology Culture, United States, Company Share (2010-2011)

11 OVERVIEW OF KEY COMPANIES IN UNITED STATES IN VITRO DIAGNOSTICS MARKET

11.1 Siemens Healthcare
11.2 Abbott Laboratories
11.3 F. Hoffmann-La Roche Ltd.
11.4 Beckman Coulter, Inc.
11.5 Ortho-Clinical Diagnostics Inc.
11.6 Alere Inc.
11.7 Danaher Corporation
11.8 bioMerieux S.A.
11.9 Becton, Dickinson and Company
11.10 Bio-Rad Laboratories, Inc.
11.11 Sysmex Corporation
11.12 Qiagen N.V.
11.13 Gen-Probe Incorporated
11.14 DiaSorin S.p.A
11.15 Immucor, Inc.
11.16 Cepheid
11.17 Thermo Fisher Scientific Inc.
11.18 Hologic, Inc.
11.19 PerkinElmer, Inc.
11.20 Grifols, S.A.
11.21 Olympus Corporation
11.22 Horiba, Ltd.
11.23 Life Technologies Corporation
11.24 Diagnostica Stago, Inc.
11.25 ELITech Group
11.26 OraSure Technologies, Inc.

12 IN VITRO DIAGNOSTICS MARKET PIPELINE PRODUCTS

12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology And Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products

13 FINANCIAL DEALS LANDSCAPE

13.1 Acquisition
13.2 Partnerships

14 RECENT DEVELOPMENTS

14.1 Strategy And Business Planning
14.2 Research And Development
14.3 Legal and Regulatory
14.4 Government and Public Interest
14.5 Product News

15 APPENDIX

15.1 Definitions of Markets Covered in the Report
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Contact Us
15.10 Disclaimer

LIST OF TABLES

Table 1: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: In Vitro Diagnostics Market, United States, Category Contribution (%), 2011
Table 3: In Vitro Diagnostics Market, United States, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: Clinical Chemistry Market, United States, Segment Contribution (%), 2011
Table 8: Clinical Chemistry, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: Clinical Chemistry, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: Clinical Chemisty Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 11: Clinical Chemisty Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 12: Urine Analysis, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 13: Urine Analysis, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 14: Clinical Chemistry, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Clinical Chemistry, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing Market, United States, Segment Contribution (%), 2011
Table 17: Genetic Testing, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Genetic Testing, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Genetic Testing, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Genetic Testing, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Haematology Market, United States, Segment Contribution (%), 2011
Table 22: Haematology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 23: Haematology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 24: Haematology Reagents, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 25: Haematology Reagents, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 26: Immunohaematology, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 27: Immunohaematology, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 28: Haemostasis, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 29: Haemostasis, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 30: Haematology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 31: Haematology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 32: Haematology Cell Counters, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 33: Haematology Cell Counters, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 34: Haematology, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Haematology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Histology And Cytology Market, United States, Segment Contribution (%), 2011
Table 37: Histology And Cytology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 38: Histology And Cytology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 39: Histology And Cytology, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Histology And Cytology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Immuno Chemistry Market, United States, Segment Contribution (%), 2011
Table 42: Immuno Chemistry, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 43: Immuno Chemistry, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 44: Disease Specific Immunochemistry, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 45: Disease Specific Immunochemistry, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 46: Drugs of Abuse / Toxicology, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 47: Drugs of Abuse / Toxicology, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 48: Endocrinology Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 49: Endocrinology Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 50: Immunochemistry Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 51: Immunochemistry Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 52: Therapeutic Drug Monitoring, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 53: Therapeutic Drug Monitoring, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 54: Immunochemistry Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 55: Immunochemistry Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 56: Immuno Chemistry, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Immuno Chemistry, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Infectious Immunology Market, United States, Segment Contribution (%), 2011
Table 59: Infectious Immunology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 60: Infectious Immunology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 61: Infectious Immunology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 62: Infectious Immunology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 63: Infectious Immunology, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 64: Infectious Immunology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Microbiology Culture Market, United States, Segment Contribution (%), 2011
Table 66: Microbiology Culture, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 67: Microbiology Culture, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 68: Microbiology Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 69: Microbiology Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 70: Microbiology Culture, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: Microbiology Culture, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 72: Clinical Chemisty Market Pipeline Products
Table 73: Immuno Chemistry Market Pipeline Products
Table 74: Haematology Market Pipeline Products
Table 75: Infectious Immunology Market Pipeline Products
Table 76: Microbiology Culture Market Pipeline Products
Table 77: Histology And Cytology Market Pipeline Products
Table 78: Genetic Testing Market Pipeline Products
Table 79: ERBA Diagnostics Acquires Drew Scientific, Maker Of Analytical Instruments And Reagents, For $6.5 Million
Table 80: Measurement Specialties Acquires Cambridge Technologies And Resistance Temperature Detector Company For $18.8 Million
Table 81: Atossa Genetics Acquires Acueity Healthcare, Diagnostic Device Provider
Table 82: AccelPath Acquires DigiPath Solutions For $2.4 Million
Table 83: Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic Test Maker, For $324 Million
Table 84: Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For $17 Million
Table 85: Leica Biosystems Completes Acquisition Of Aperio Technologies
Table 86: Metabolon Acquires Lipomics Technologies, Diagnostics Company
Table 87: Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For $14 Million
Table 88: Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company
Table 89: Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For $925 Million
Table 90: Life Technologies Acquires Navigenics
Table 91: Genova Diagnostics Acquires Metametrix, Clinical Laboratory
Table 92: Luminex To Acquire GenturaDx, Molecular Diagnostics Company, For $50 Million
Table 93: Systagenix Acquires O2 Insights
Table 94: LabCorp Completes Acquisition Of Medtox Scientific For $241 Million
Table 95: Flagship Biosciences Acquires Ihctech, Provider Of Research Immunohistochemistry And Histology Services
Table 96: Halo Healthcare Acquires NeoMatrix, Maker Of Diagnostic Equipments
Table 97: Qiagen Acquires AmniSure International, Manufacturer Of Non Invasive Test Solutions
Table 98: Hologic Completes Acquisition Of Gen-Probe For $3.7 Billion
Table 99: Haemonetics To Acquire Hemerus Medical, Provider Of Leukoreduction Technologies, For $27 Million
Table 100: IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences
...

LIST OF FIGURES

Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2011
Figure 4: In Vitro Diagnostics Market, United States, Category Contribution (%), 2011
Figure 5: In Vitro Diagnostics Market, United States, Cross-Category Analysis, 2004-2018
Figure 6: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: In Vitro Diagnostics, United States, Company Share (%), 2011
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, United States, Revenue Mix ($m), 2011
Figure 11: Clinical Chemistry Market, United States, Segment Contribution (%), 2011
Figure 12: Clinical Chemistry, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Clinical Chemistry, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Clinical Chemisty Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Clinical Chemisty Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Urine Analysis, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 17: Urine Analysis, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 18: Clinical Chemistry, United States, Company Share (%), 2011
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, United States, Revenue Mix ($m), 2011
Figure 21: Genetic Testing Market, United States, Segment Contribution (%), 2011
Figure 22: Genetic Testing, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 23: Genetic Testing, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 24: Genetic Testing, United States, Company Share (%), 2011
Figure 25: Haematology Market, Market Segmentation
Figure 26: Haematology Market, United States, Revenue Mix ($m), 2011
Figure 27: Haematology Market, United States, Segment Contribution (%), 2011
Figure 28: Haematology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Haematology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Haematology Reagents, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 31: Haematology Reagents, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 32: Immunohaematology, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 33: Immunohaematology, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 34: Haemostasis, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 35: Haemostasis, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 36: Haematology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 37: Haematology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 38: Haematology Cell Counters, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 39: Haematology Cell Counters, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 40: Haematology, United States, Company Share (%), 2011
Figure 41: Histology and Cytology Market, Market Segmentation
Figure 42: Histology And Cytology Market, United States, Revenue Mix ($m), 2011
Figure 43: Histology And Cytology Market, United States, Segment Contribution (%), 2011
Figure 44: Histology And Cytology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Histology And Cytology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Histology And Cytology, United States, Company Share (%), 2011
Figure 47: Infectious Immunology, Market Segmentation
Figure 48: Immuno Chemistry Market, United States, Revenue Mix ($m), 2011
Figure 49: Immuno Chemistry Market, United States, Segment Contribution (%), 2011
Figure 50: Immuno Chemistry, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 51: Immuno Chemistry, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 52: Disease Specific Immunochemistry, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 53: Disease Specific Immunochemistry, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 54: Drugs of Abuse / Toxicology, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 55: Drugs of Abuse / Toxicology, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 56: Endocrinology Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 57: Endocrinology Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 58: Immunochemistry Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 59: Immunochemistry Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 60: Therapeutic Drug Monitoring, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 61: Therapeutic Drug Monitoring, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 62: Immunochemistry Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 63: Immunochemistry Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 64: Immuno Chemistry, United States, Company Share (%), 2011
Figure 65: Infectious Immunology Market, United States, Revenue Mix ($m), 2011
Figure 66: Infectious Immunology Market, United States, Segment Contribution (%), 2011
Figure 67: Infectious Immunology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 68: Infectious Immunology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 69: Infectious Immunology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 70: Infectious Immunology Rapid Tests, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 71: Infectious Immunology, United States, Company Share (%), 2011
Figure 72: Microbiology Culture, Market Segmentation
Figure 73: Microbiology Culture Market, United States, Revenue Mix ($m), 2011
Figure 74: Microbiology Culture Market, United States, Segment Contribution (%), 2011
Figure 75: Microbiology Culture, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 76: Microbiology Culture, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 77: Microbiology Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 78: Microbiology Analyzers, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 79: Microbiology Culture, United States, Company Share (%), 2011
Figure 80: Siemens Healthcare, Company Share (%),United States In Vitro Diagnostics Market, 2011
Figure 81: Abbott Laboratories, Company Share (%),United States In Vitro Diagnostics Market, 2011
Figure 82: F. Hoffmann-La Roche Ltd., Company Share (%),United States In Vitro Diagnostics Market, 2011
Figure 83: Beckman Coulter, Inc., Company Share (%),the United States In Vitro Diagnostics Market, 2011
Figure 84: Ortho-Clinical Diagnostics Inc., Company Share (%),the United States In Vitro Diagnostics Market, 2011
Figure 85: Alere Inc., Company Share (%),United States In Vitro Diagnostics Market, 2011

COMPANIES MENTIONED

Siemens Healthcare
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Alere Inc.
Danaher Corporation
bioMerieux S.A.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Qiagen N.V.
Gen-Probe Incorporated
DiaSorin S.p.A
Immucor, Inc.
Cepheid
Thermo Fisher Scientific Inc.
Hologic, Inc.
PerkinElmer, Inc.
Grifols, S.A.
Olympus Corporation
Horiba, Ltd.
Life Technologies Corporation
Diagnostica Stago, Inc.
ELITech Group
OraSure Technologies, Inc.

Ask Your Question

United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: